SEC Form D filing

EtiraRX, Inc.

Biotech · Series A · Regulation D 506(b) · TX · Filed May 14, 2026

Offering amount: $3.0M
Exemption: Reg D 506(b)
Issuer state: TX
Filing date: May 14, 2026
Signature date: May 13, 2026
CIK: 0001996442

Public filing directories

Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Sector: Biotech Month: May 2026 Stage and month: Series A

Summary

Auto-generated

EtiraRX rare disease biotech; $3M offering anchors to series-a.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.